World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
14790
World Ranking
2685
National Ranking
68

Overview

Roland W. Sutter is affiliated with the World Health Organization in Switzerland. Their research primarily focuses on medicine, with significant contributions to the fields of infectious diseases, cardiology and cardiovascular medicine, epidemiology, modeling and simulation, and immunology.

Their scientific work covers multiple main topics, including:

  • Viral Infections and Immunology Research
  • Viral gastroenteritis research and epidemiology
  • SARS-CoV-2 and COVID-19 Research
  • Respiratory viral infections research
  • COVID-19 epidemiological studies
  • Immunodeficiency and Autoimmune Disorders
  • Celiac Disease Research and Management

Roland W. Sutter has published extensively in renowned journals. Frequent publication venues include:

  • The Journal of Infectious Diseases
  • Science
  • Pathogens
  • MMWR Morbidity and Mortality Weekly Report
  • Vaccine

Some of their recent scientific papers are:

  • Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine, 2020, Science
  • Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication, 2020, The Journal of Infectious Diseases
  • Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic, 2021, Vaccine
  • Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance, 2024, Pathogens
  • Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India, 2021, Journal of the Pediatric Infectious Diseases Society

Roland W. Sutter has collaborated frequently with other researchers including Harish Verma, Ondrej Mach, Ananda S Bandyopadhyay, Natalia A. Molodecky, and Vishali Jeyaseelan.

Best Publications

  • Vaccine-derived polioviruses and the endgame strategy for global polio eradication.

    Olen M. Kew;Roland W. Sutter;Esther M. de Gourville;Walter R. Dowdle

  • Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived Poliovirus

    Olen Kew;Victoria Morris-Glasgow;Mauricio Landaverde;Cara Burns

  • A Population-Based Serologic Survey of Immunity to Tetanus in the United States

    Peter J. Gergen;Geraldine M. McQuillan;Michele Kiely;Trena M. Ezzati-Rice

  • Epidemiology of Poliomyelitis in the United States One Decade after the Last Reported Case of Indigenous Wild Virus-Associated Disease

    Peter M. Strebel;Roland W. Sutter;Stephen L. Cochi;Robin J. Biellik

  • Vaccine-Derived Polioviruses

    Cara C. Burns;Ousmane M. Diop;Roland W. Sutter;Olen M. Kew

  • Vaccine-Associated Paralytic Poliomyelitis: A Review of the Epidemiology and Estimation of the Global Burden

    Lauren R Platt;Concepción F Estívariz;Roland W Sutter

  • Prolonged Replication of a Type 1 Vaccine-Derived Poliovirus in an Immunodeficient Patient

    Olen M. Kew;Roland W. Sutter;Baldev K. Nottay;Michael J. McDonough

  • Vaccine policy changes and epidemiology of poliomyelitis in the United States.

    Lorraine Niño Alexander;Jane F. Seward;Tammy A. Santibanez;Mark A. Pallansch

  • Poliovirus vaccine-live

    Roland W. Sutter;Olen M. Kew;Stephen L. Cochi

  • Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union

    I.R.B. Hardy;R.W. Sutter;S. Dittmann

  • Fractional Doses of Inactivated Poliovirus Vaccine in Oman

    Ali Jafer Mohammed;Salah AlAwaidy;Shyam Bawikar;Padmamohan J Kurup

  • Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned.

    Sieghart Dittmann;Melinda Wharton;Charles Vitek;Massimo Ciotti

  • Factors Determining Prevalence of Maternal Antibody to Measles Virus throughout Infancy: A Review

    Victor M. Cáceres;Peter M. Strebel;Roland W. Sutter

  • Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.

    Radboud J. Duintjer Tebbens;Mark A. Pallansch;Olen M. Kew;Victor M. Cáceres

  • Randomized Controlled Clinical Trial of Fractional Doses of Inactivated Poliovirus Vaccine Administered Intradermally by Needle-Free Device in Cuba

    Sonia Resik;Alina Tejeda;Pedro Mas Lago;Manuel Diaz

  • Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study

    Nicholas C Grassly;Jay Wenger;Sunita Durrani;Sunil Bahl

  • Update on Vaccine-Derived Polioviruses - Worldwide, January 2017-June 2018.

    Jaume Jorba;Ousmane M Diop;Jane Iber;Roland W Sutter

  • Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial

    Roland W Sutter;T Jacob John;Hemant Jain;Sharad Agarkhedkar

  • Priming after a Fractional Dose of Inactivated Poliovirus Vaccine

    Sonia Resik;Alina Tejeda;Roland W. Sutter;Manuel Diaz

  • Economic analysis of the global polio eradication initiative.

    Radboud J. Duintjer Tebbens;Mark A. Pallansch;Stephen L. Cochi;Steven G.F. Wassilak

Frequent Co-Authors

Mark A. Pallansch
Mark A. Pallansch National Center for Immunization and Respiratory Diseases
M. Steven Oberste
M. Steven Oberste Centers for Disease Control and Prevention
Olen M. Kew
Olen M. Kew Centers for Disease Control and Prevention
Nicholas C. Grassly
Nicholas C. Grassly Imperial College London
Peter M. Strebel
Peter M. Strebel World Health Organization
David L. Heymann
David L. Heymann London School of Hygiene & Tropical Medicine
Jay D. Wenger
Jay D. Wenger Centers for Disease Control and Prevention
John F. Modlin
John F. Modlin Bill & Melinda Gates Foundation
Stephen C. Hadler
Stephen C. Hadler Centers for Disease Control and Prevention
Zulfiqar A Bhutta
Zulfiqar A Bhutta Aga Khan University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with advanced nursing and healthcare roles. For those interested in expanding their expertise, enrolling in an accelerated NP program can provide an efficient pathway to becoming a nurse practitioner with specialized skills.

Healthcare professionals seeking certification might consider the acute care nurse practitioner certification, which allows nurses to manage complex patients in critical settings—a valuable complement to immunology knowledge.

For aspiring nurses without prior clinical experience, online RN programs for non nurses in Florida offer accessible routes to enter the nursing field, building foundational skills that support careers involving immunological research and patient care.

Understanding compensation is also important when planning a healthcare career. Exploring data on how much does a DNP make helps prospective students gauge the financial benefits of advanced degrees in nursing and immunology-related roles across different states.

Best Scientists Citing Roland W. Sutter

Trending Scientists